心血管醫療設備市場規模、佔有率和成長分析：按產品、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球心血管醫療設備市場價值為 600 億美元，預計到 2025 年將成長至 2033 年的 1,199.4 億美元，預測期（2026-2033 年）複合年成長率為 8.0%。

全球心血管器材市場正經歷強勁成長，主要驅動力是慢性心血管疾病盛行率的不斷上升。冠狀動脈支架和搭橋手術等基本心臟治療的成本效益顯著，尤其是在新興市場，並推動了這些治療手段的普及應用。該市場的關鍵促進因素包括技術的快速進步、全球心臟病負擔的加重以及微創治療的興起。心肌梗塞和中風等疾病是導致心臟相關死亡的重要因素，因此亟需有效的治療方案。此外，心臟醫療設備製造技術的進步正在拓展其應用範圍，並改善患者照護和治療效果。這些進展凸顯了心血管醫療設備在應對全球日益嚴峻的心臟病健康挑戰方面所發揮的關鍵作用。

全球心血管醫療設備市場的成長要素

全球心血管器材市場的主要驅動力是心血管疾病（CVD）的廣泛流行，心血管疾病是全球主要死因之一。久坐不動的生活方式、不健康的飲食習慣以及人口老化加劇了嚴重心血管疾病（包括心臟衰竭和高血壓）的風險。因此，已開發國家和開發中國家對心律調節器、去心房顫動和支架等緊急醫療器材的需求都在不斷成長。在醫院和診所採用先進技術以改善患者預後的推動下，醫療保健系統越來越重視預防醫學和疾病早期檢測。同時，各種政府主導的計劃和非營利組織也在努力提高高風險族群的疾病意識。

全球心血管醫療設備市場的限制因素

尤其是在發展中地區，心血管設備普及應用的最大障礙之一是這些先進技術的高成本。植入式心臟整流去顫器（ICD）和最先進的影像技術等醫療設備價格往往高得令人望而卻步，醫療服務提供者和病患都可能難以負擔。某些地區保險覆蓋範圍和報銷制度的不足進一步加劇了這種經濟負擔，限制了需要救命治療的患者獲得治療的機會。因此，許多人可能無法獲得能夠顯著改善其健康狀況的所需醫療設備。

全球心血管醫療設備市場趨勢

在全球循環系統醫療設備市場中，受技術進步和對患者自我管理日益重視的推動，居家醫療解決方案正發生顯著轉變。穿戴式心電圖設備、血壓監測儀和創新的遠端患者監護系統使人們能夠在家中舒適地管理心血管健康。這一趨勢能夠即時收集數據，並對心臟衰竭等慢性疾病進行主動管理，從而最大限度地減少頻繁就醫的需求。透過提高醫療服務的可近性和降低醫療成本，這一趨勢正在開啟預防醫學的新時代，並將心血管疾病管理轉變為更有效率、以患者為中心的模式。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球心血管醫療設備市場規模：依產品類別分類

• 診斷和監測設備
  • 心電圖
  • 植入式心臟監測器
  • 心電圖監測
  • 移動心電遙測
  • MRI
  • PET掃描儀
  • 心血管超音波診斷設備（2D、3D/4D、多普勒）
  • 心臟診斷導管
  • 其他
• 治療及外科器械
  • 心臟再同步治療（CRT）
  • 植入式心臟整流去顫器（ICD）
  • 心臟節律器（傳統型和無導線型）
  • 冠狀動脈支架
  • 導管、導管導引線、套管
  • 瓣膜和閉塞裝置
  • 其他

全球心血管醫療設備市場規模：按應用領域分類

• 冠狀動脈疾病（CAD）
• 心律不整
• 心臟衰竭
• 其他

全球心血管醫療設備市場規模：依最終用戶分類

• 醫院
• 專科診所
• 其他

全球心血管醫療設備市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic
• Abbott
• Boston Scientific
• Edwards Lifesciences
• Johnson & Johnson
• Terumo
• BIOTRONIK
• LivaNova
• GE HealthCare
• Siemens Healthineers
• Philips
• Canon Medical Systems
• B. Braun
• Baxter International
• Getinge
• Nihon Kohden
• WL Gore & Associates
• Schiller
• Fujifilm Holdings
• Hitachi

結論與建議

Global Cardiovascular Devices Market size was valued at USD 60.0 Billion in 2024 and is poised to grow from USD 64.8 Billion in 2025 to USD 119.94 Billion by 2033, growing at a CAGR of 8.0% during the forecast period (2026-2033).

The global cardiovascular devices market is experiencing robust growth, largely fueled by the rising prevalence of chronic cardiovascular diseases. The affordability of essential cardiac interventions, such as coronary stents and bypass therapies, is particularly impactful in emerging markets, driving wider adoption. Key factors propelling this market include rapid technological advancements, a growing global burden of heart diseases, and a shift toward less invasive treatment options. Conditions like myocardial infarction and stroke contribute significantly to heart-related mortality rates, necessitating effective management solutions. Additionally, advancements in manufacturing technologies for cardiac devices have broadened their applications, enhancing patient care and outcomes. These developments underscore the critical role cardiovascular devices play in addressing the escalating health challenges posed by heart diseases worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiovascular Devices Market Segments Analysis

Global Cardiovascular Devices Market is segmented by Product, Application, End-User and region. Based on Product, the market is segmented into Diagnostic & Monitoring Devices and Therapeutic & Surgical Devices. Based on Application, the market is segmented into Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure and Others. Based on End-User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is significantly driven by the pervasive prevalence of cardiovascular diseases (CVDs), which rank as the foremost cause of mortality worldwide. The rising incidence of sedentary lifestyles, unhealthy dietary habits, and an increasingly aging population are contributing factors that elevate the risk of serious cardiovascular conditions, including heart failure and hypertension. Consequently, there is a growing necessity for life-saving medical devices such as pacemakers, defibrillators, and stents across both developed and developing regions. Healthcare systems are increasingly focusing on preventive care and early disease detection, fueled by hospitals and clinics adopting advanced technologies to enhance patient outcomes while various government initiatives and nonprofits work to raise awareness among high-risk groups.

Restraints in the Global Cardiovascular Devices Market

One of the significant obstacles hindering the adoption of cardiovascular devices, particularly in developing regions, is the high cost associated with these advanced technologies. Devices such as implantable cardioverter defibrillators (ICDs) and cutting-edge imaging techniques often come with substantial price tags that can be beyond the reach of healthcare providers and patients alike. This financial burden is further intensified by inadequate insurance coverage and reimbursement options in certain areas, which restricts access for patients in need of life-saving treatments. As a result, many individuals may be unable to obtain the necessary devices that could significantly improve their health outcomes.

Market Trends of the Global Cardiovascular Devices Market

The Global Cardiovascular Devices market is experiencing a significant shift towards home health solutions, driven by advancements in technology and a growing emphasis on patient self-management. Wearable ECG devices, blood pressure monitors, and innovative remote patient monitoring systems are empowering individuals to take control of their cardiovascular health from the comfort of their homes. This trend is facilitating real-time data collection, enabling proactive management of chronic conditions such as heart failure while minimizing the need for frequent hospital visits. By enhancing accessibility and reducing healthcare costs, this movement is ushering in a new era of preventative healthcare, making cardiovascular management both efficient and patient-centric.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global Cardiovascular Devices Market Size by Product & CAGR (2026-2033)

• Market Overview
• Diagnostic & Monitoring Devices
  • ECG
  • Implantable Cardiac Monitors
  • Holter Monitors
  • Mobile Cardiac Telemetry
  • MRI
  • PET Scanner
  • Cardiovascular Ultrasound (2D, 3D/4D, Doppler)
  • Cardiac Diagnostic Catheters
  • Others
• Therapeutic & Surgical Devices
  • Cardiac Resynchronization Therapy (CRT)
  • Implantable Cardioverter Defibrillators (ICDs)
  • Pacemakers (Conventional, Leadless)
  • Coronary Stents
  • Catheters, Guidewires, Cannula
  • Valves & Occlusion Devices
  • Others

Global Cardiovascular Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Coronary Artery Disease (CAD)
• Cardiac Arrhythmia
• Heart Failure
• Others

Global Cardiovascular Devices Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Cardiovascular Devices Market Size & CAGR (2026-2033)

• North America (Product, Application, End-User)
  • US
  • Canada
• Europe (Product, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations